Literature DB >> 8408253

Biomechanical evaluation of operative procedures to treat Kienböck's disease.

F W Werner1, A K Palmer.   

Abstract

Operative procedures used to treat Kienböck's disease have been biomechanically evaluated experimentally. We have shown that joint leveling procedures, such as radial shortening and ulnar lengthening, experimentally unload the ulna and the radial lunate fossa. For wrists with neutral ulnar variance, a lateral opening or medial closing radial wedge procedure unloads the radial lunate fossa. Scapho-trapezio-trapezoidal fusion and scapho-capitate fusion also unload the radial lunate fossa but at the expense of loading the adjacent joints. Neither a capitate-hamate fusion nor a carpal tunnel release alter the radial ulnar carpal joint loading.

Entities:  

Mesh:

Year:  1993        PMID: 8408253

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  5 in total

Review 1.  [Indications and techniques for wrist arthroscopy].

Authors:  A Ewert; T Mittlmeier
Journal:  Unfallchirurg       Date:  2007-01       Impact factor: 1.000

2.  Vascularized bone grafts and their applications in the treatment of carpal pathology.

Authors:  Marco Rizzo; Steven L Moran
Journal:  Semin Plast Surg       Date:  2008-08       Impact factor: 2.314

3.  The Proposal and Early Results of Capitate Forage as a New Treatment Method for Kienböck's Disease.

Authors:  Halil Ibrahim Bekler; Yiğit Erdag; Seyit Ali Gumustas; Gökhan Pehlivanoglu
Journal:  J Hand Microsurg       Date:  2013-06-15

4.  Single-Cut Single-Screw Capitate-Shortening Osteotomy for Kienbock's Disease.

Authors:  Gregory I Bain; Sathya Vamsi Krishna; Simon Bruce Murdoch MacLean; Parth Agrawal
Journal:  J Wrist Surg       Date:  2020-05-01

5.  Changes in wrist joint contact area following radial shortening osteotomy for Kienböck's disease.

Authors:  Junki Shiota; Daisuke Momma; Yuichiro Matsui; Nozomu Inoue; Eiji Kondo; Norimasa Iwasaki
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.